Barclays PLC (NYSE: BCS ) is trading at a relatively low valuation and has reported a positive performance in Q3 2024 , but a re-rating of its shares is not much likelier ahead. Labutes IR is a Fund Manager/Analyst specialized in the financial sector, with more than 18 years of experience in the financial markets. I have worked at several type of institutions in the industry, always at the buy side and related to portfolio management. Associated with the existing author The Outsider. Analyst's Disclosure: I ...

Barclays PLC (NYSE:BCS) Q3 2024 Earnings Conference Call October 24, 2024 4:30 AM ET Company Participants C.S. Venkatakrishnan - Group Chief Executive Angela Cross - Group Finance Director Conference Call Participants Jason Napier - UBS Benjamin Toms - RBC Chris Cant - Autonomous Edward Firth - KBW Guy Stebbings - BNP Paribas Amit Goel - Mediobanca Chris Hallam - Goldman Sachs Alvaro Serrano - Morgan Stanley Robin Down - HSBC Perlie Mong - Bank of America Merrill Lynch Andrew Coombs - Citi Group Operator We ...

Barclays’ (BCS) third-quarter 2024 net income attributable to ordinary equity holders of £1.56 billion ($2.03 billion) grew 23% year over year.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Shares of BCS on NYSE gained 4% in pre-market trading as profit increased. Investors also cheered an upward tweak in net interest income (NII) 2024 guidance.An increase in revenues (driven by solid investment banking performance), stable operating expenses (showing the success of cost-efficiency ...

LONDON — British bank Barclays on Thursday reported £1.6 billion ($2 billion) net profit attributable to shareholders for the third quarter, beating expectations.The result compared with the £1.17 billion net profit forecast in an LSEG poll of analysts, and was 23% higher than the same period in 2023.Revenue for the period came in at £6.5 billion, slightly ahead of a forecast of £6.39 billion.The lender's return on tangible equity rose to 12.3% from 9.9% in the second quarter, as its CET1 ratio — a measure ...

Barclays US Consumer Bank will become the exclusive issuer of General Motors' GM Rewards Mastercard and GM Business Mastercard in the United States in the summer of 2025 and will acquire the card program's receivables from the current issuer — Goldman Sachs — next year. The bank and the automaker announced their new long-term partnership agreement in a Monday (Oct. 14) press release. "As a leading and experienced player in the U.S. partner card market with a winning formula for growing partner programs, we ...

Barclays upgraded CVS Health Inc CVS on higher Pharmacy & Consumer Wellness (PCW) estimates as headwinds are offset by share gains, with further upside potential from CostVantage.Despite macroeconomic pressures impacting the retail pharmacy sector, the analyst writes that CVS has shown resilience thanks to its diversified business model.Also Read: CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit.This has allowed the company to mitigate some of these challenges and c ...

Key TakeawaysRobinhood Markets announced it would hold its first investor day on Dec. 4.Barclays raised its price target on the stock as the analysts see momentum in the business likely to continue.Shares of Robinhood have almost doubled in 2024. Robinhood Markets (HOOD) shares jumped Tuesday after the online trading platform announced its first investor day, and Barclays gave a positive view of the company in its third-quarter outlook for the brokerage industry. Robinhood said the investor day would be hel ...

Key TakeawaysStellantis reported U.S. sales slumped 20% year-over-year in the third quarter as all of its brands except Fiat posted declines.The automaker will continue to offer incentives begun in the beginning of the quarter through the rest of the year.Barclays analysts downgraded the stock, saying they see no sign of recovery until the first half of next year at the earliest. Stellantis (STLA) shares fell Thursday after the automaker's U.S. unit reported a big drop in sales as all but one of its brands ...

– Perimeter OCT B-Series is the first system designed to combine AI with optical coherence tomography for margin assessment, with the aim of reducing the unacceptably high reoperation rates associated with BCS –– Recent study1 published in the Annals of Surgical Oncology revealed reoperation rates of 21.1% among commercially insured women and 14.9% among the Medicare cohort –– Primary endpoint results from OCT B-Series pivotal trial expected in Q4-2024; could support submission to FDA in 2025 –– First-ever ...

Investors interested in stocks from the Banks - Foreign sector have probably already heard of Barclays (BCS) and Nordea Bank AB (NRDBY) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The Zacks Rank is a proven strategy that target ...